Nexgard Spectra 150 mg / 30 mg Chewable Tablets for dogs >30–60 kg

• Target species: Dogs
• Active substances: Afoxolaner, Milbemycin Oxime (A3 and A4)
• Pharmaceutical form: Chewable tablet
• Therapeutic group: Endectocide
• Authorisation route: Centralised
• Legal category: POM-V
• Controlled drug status: Not a controlled drug
• Marketing Authorisation holder: Boehringer Ingelheim Vetmedica Gmbh
• Distributors:
• Territory: Northern Ireland
• SPC: https://www.ema.europa.eu/en/veterinary-regulatory-overview/veterinary-medicinal-products-regulation/union-product-database
• UKPAR: